2BB score and signals
Black Diamond Therapeutics, Inc.’s current 2BB score is 21 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 34 | Weak |
| Quality | 40 | Normal |
| Risk | 42 | Moderate |
Company facts
| Founded | 2014 |
| Employees | 21 |
| 52-week range | $1.60 – $4.94 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-04 | — | -0.1998 | — | $0.00 |
| 2026-08-06 | — | -0.1993 | — | $0.00 |
| 2026-05-07 | -0.16 | -0.1884 | $0.00 | $0.00 |
| 2026-03-16 | -0.27 | -0.19 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish